Atai Life Sciences founder on using psychedelics to treat mental illness

Atai Life Sciences, a biotech company that uses psychedelics to treat mental illness, is going public on the Nasdaq Friday. Christian Angermayer, Atai Life Sciences founder, joined "Squawk Box" on Friday to discuss the company's mission and public debut.